Burst of FDA Approvals; Monkeypox Poses 'Moderate' Threat; Hep A in Strawberries?

(MedPage Today) -- Note that some links may require registration or subscription. The FDA expanded the indication for risdiplam (Evrysdi) to include treatment of spinal muscular atrophy in infants under 2 months of age, drugmaker Roche announced...
Source: MedPage Today Public Health - Category: American Health Source Type: news